Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms 1

Interventions

Nivolumab 2Docetaxel 2gallium 68 PSMA-11 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Watchful Waiting 1Specimen Handling 1Paclitaxel 1Observation 1Menogaril 1Magnetic Resonance Imaging 1Interleukin-2 1Genome 1Genetic Testing 1Etoposide 1Cisplatin 1Carboplatin 1CYT003-QbG10 1Biopsy 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × abarelix × Clear all
NCT00103623 2006-09-19

The Plenaxis® Experience Study

PRAECIS Pharmaceuticals Inc.

Phase 4 Suspended
2,000 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡